Macrophagic Stabilin-1 Restored Disruption of Vascular Integrity Caused by Sepsis

Wonhwa Lee; Seung-Yoon Park; Youngbum Yoo; Soon-Young Kim; Jung-Eun Kim; Shin-Woo Kim; Young-Kyo Seo; Eui Kyun Park; In-San Kim; Jong-Sup Bae

doi:10.1055/s-0038-1669477

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 2018; 118(10): 1776-1789
DOI: 10.1055/s-0038-1669477

Blood Cells, Inflammation and Infection

Georg Thieme Verlag KG Stuttgart · New York

Macrophagic Stabilin-1 Restored Disruption of Vascular Integrity Caused by Sepsis

Wonhwa Lee

¹College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea

²Aging Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Deajeon, Republic of Korea

,

Seung-Yoon Park

³Department of Biochemistry, School of Medicine, Dongguk University, Gyeongju, Republic of Korea

,

Youngbum Yoo

²Aging Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Deajeon, Republic of Korea

,

Soon-Young Kim

⁴Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea

,

Jung-Eun Kim

⁴Department of Molecular Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea

,

Shin-Woo Kim

⁵Department of Internal Medicine, School of Medicine, Kyungpook National University, Daegu, Republic of Korea

,

Young-Kyo Seo

²Aging Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Deajeon, Republic of Korea

,

Eui Kyun Park

⁶Department of Pathology and Regenerative Medicine, School of Dentistry, Kyungpook National University, Daegu, Republic of Korea

,

In-San Kim

⁷Biomedical Research Institute, Korea Institute of Science and Technology, Seoul, Republic of Korea

⁸KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul, Republic of Korea

,

Jong-Sup Bae

¹College of Pharmacy, Research Institute of Pharmaceutical Sciences, Kyungpook National University, Daegu, Republic of Korea

› Institutsangaben

Abstract

Sepsis develops because of overwhelming inflammatory responses to bacterial infection, and disrupts vascular integrity. Stabilin-1 (STAB-1) is a phagocytic receptor, which mediates efferocytosis in a phosphatidylserine (PS)-dependent manner. STAB-1 is expected to play important roles in efferocytosis during sepsis. Here, we determined the role of STAB-1 in maintaining and restoring vascular integrity. Macrophages and vascular endothelial cells were used to assess the effect of STAB-1 on survival rate, phagocytic activity, vascular permeability and transendothelial migration (TEM). Additionally, we investigated whether the high-mobility group box 1 (HMGB1)-receptor for advanced glycated end products complex interfered with the binding of Stab1 to PS. Mortality rate was higher in the Stab1-knockout mice than in the wild-type mice, and STAB-1 deficiency was related to reduced macrophage-mediated efferocytosis and the disruption of vascular integrity, which increased vascular permeability, and enhanced TEM. STAB-1 deficiency promoted lung injury, and elevated the expression of sepsis markers. The exogenous application of the anti-HMGB1 neutralizing antibody improved efferocytosis, vascular integrity and survival rate in sepsis. Collectively, our findings indicated that STAB-1 regulated and maintained vascular integrity through the clearance of infected apoptotic endothelial cells. Moreover, our results suggested that interventions targeting vascular integrity by STAB-1 signalling are promising therapeutic approaches to sepsis.

Keywords

STAB-1 - efferocytosis - sepsis - vascular integrity - phagocytosis

Volltext

Referenzen

References
1 Gustot T. Multiple organ failure in sepsis: prognosis and role of systemic inflammatory response. Curr Opin Crit Care 2011; 17 (02) 153-159
2 Angus DC, van der Poll T. Severe sepsis and septic shock. N Engl J Med 2013; 369 (09) 840-851
3 Kellum JA. Metabolic acidosis in patients with sepsis: epiphenomenon or part of the pathophysiology?. Crit Care Resusc 2004; 6 (03) 197-203
4 Bogatcheva NV, Verin AD. The role of cytoskeleton in the regulation of vascular endothelial barrier function. Microvasc Res 2008; 76 (03) 202-207
5 Gupta S, Agrawal A, Agrawal S, Su H, Gollapudi S. A paradox of immunodeficiency and inflammation in human aging: lessons learned from apoptosis. Immun Ageing 2006; 3: 5
6 Botto M, Dell'Agnola C, Bygrave AE. , et al. Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat Genet 1998; 19 (01) 56-59
7 Douglas IS, Diaz del Valle F, Winn RA, Voelkel NF. Beta-catenin in the fibroproliferative response to acute lung injury. Am J Respir Cell Mol Biol 2006; 34 (03) 274-285
8 Henson PM, Cosgrove GP, Vandivier RW. State of the art. Apoptosis and cell homeostasis in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2006; 3 (06) 512-516
9 Ravichandran KS, Lorenz U. Engulfment of apoptotic cells: signals for a good meal. Nat Rev Immunol 2007; 7 (12) 964-974
10 Savill J, Dransfield I, Gregory C, Haslett C. A blast from the past: clearance of apoptotic cells regulates immune responses. Nat Rev Immunol 2002; 2 (12) 965-975
11 Kzhyshkowska J, Gratchev A, Goerdt S. Stabilin-1, a homeostatic scavenger receptor with multiple functions. J Cell Mol Med 2006; 10 (03) 635-649
12 Goerdt S, Bhardwaj R, Sorg C. Inducible expression of MS-1 high-molecular-weight protein by endothelial cells of continuous origin and by dendritic cells/macrophages in vivo and in vitro. Am J Pathol 1993; 142 (05) 1409-1422
13 Politz O, Gratchev A, McCourt PA. , et al. Stabilin-1 and -2 constitute a novel family of fasciclin-like hyaluronan receptor homologues. Biochem J 2002; 362 (Pt 1): 155-164
14 Adachi H, Tsujimoto M. FEEL-1, a novel scavenger receptor with in vitro bacteria-binding and angiogenesis-modulating activities. J Biol Chem 2002; 277 (37) 34264-34270
15 Tamura Y, Adachi H, Osuga J. , et al. FEEL-1 and FEEL-2 are endocytic receptors for advanced glycation end products. J Biol Chem 2003; 278 (15) 12613-12617
16 Park SY, Jung MY, Lee SJ. , et al. Stabilin-1 mediates phosphatidylserine-dependent clearance of cell corpses in alternatively activated macrophages. J Cell Sci 2009; 122 (Pt 18): 3365-3373
17 Park SY, Bae DJ, Kim MJ, Piao ML, Kim IS. Extracellular low pH modulates phosphatidylserine-dependent phagocytosis in macrophages by increasing stabilin-1 expression. J Biol Chem 2012; 287 (14) 11261-11271
18 Rodríguez CI, Buchholz F, Galloway J. , et al. High-efficiency deleter mice show that FLPe is an alternative to Cre-loxP. Nat Genet 2000; 25 (02) 139-140
19 O'Gorman S, Dagenais NA, Qian M, Marchuk Y. Protamine-Cre recombinase transgenes efficiently recombine target sequences in the male germ line of mice, but not in embryonic stem cells. Proc Natl Acad Sci U S A 1997; 94 (26) 14602-14607
20 Bone RC, Balk RA, Cerra FB. , et al; The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101 (06) 1644-1655
21 Bone RC, Sibbald WJ, Sprung CL. The ACCP-SCCM consensus conference on sepsis and organ failure. Chest 1992; 101 (06) 1481-1483
22 Sallusto F, Lanzavecchia A. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor alpha. J Exp Med 1994; 179 (04) 1109-1118
23 Verreck FA, de Boer T, Langenberg DM. , et al. Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria. Proc Natl Acad Sci U S A 2004; 101 (13) 4560-4565
24 Lee SJ, Park SY, Jung MY, Bae SM, Kim IS. Mechanism for phosphatidylserine-dependent erythrophagocytosis in mouse liver. Blood 2011; 117 (19) 5215-5223
25 Ding AH, Nathan CF, Stuehr DJ. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. J Immunol 1988; 141 (07) 2407-2412
26 Albina JE, Cui S, Mateo RB, Reichner JS. Nitric oxide-mediated apoptosis in murine peritoneal macrophages. J Immunol 1993; 150 (11) 5080-5085
27 Yoon EK, Ku SK, Lee W. , et al. Antitcoagulant and antiplatelet activities of scolymoside. BMB Rep 2015; 48 (10) 577-582
28 Lee W, Seo J, Kwak S. , et al. A double-chambered protein nanocage loaded with thrombin receptor agonist peptide (TRAP) and γ-carboxyglutamic acid of protein C (PC-Gla) for sepsis treatment. Adv Mater 2015; 27 (42) 6637-6643
29 Lawrence T, Natoli G. Transcriptional regulation of macrophage polarization: enabling diversity with identity. Nat Rev Immunol 2011; 11 (11) 750-761
30 Kigerl KA, Gensel JC, Ankeny DP, Alexander JK, Donnelly DJ, Popovich PG. Identification of two distinct macrophage subsets with divergent effects causing either neurotoxicity or regeneration in the injured mouse spinal cord. J Neurosci 2009; 29 (43) 13435-13444
31 García A, Serrano A, Abril E. , et al. Differential effect on U937 cell differentiation by targeting transcriptional factors implicated in tissue- or stage-specific induced integrin expression. Exp Hematol 1999; 27 (02) 353-364
32 Rittirsch D, Huber-Lang MS, Flierl MA, Ward PA. Immunodesign of experimental sepsis by cecal ligation and puncture. Nat Protoc 2009; 4 (01) 31-36
33 Wang H, Liao H, Ochani M. , et al. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 2004; 10 (11) 1216-1221
34 Akeson AL, Woods CW. A fluorometric assay for the quantitation of cell adherence to endothelial cells. J Immunol Methods 1993; 163 (02) 181-185
35 Kim TH, Ku SK, Lee IC, Bae JS. Anti-inflammatory functions of purpurogallin in LPS-activated human endothelial cells. BMB Rep 2012; 45 (03) 200-205
36 Bae JS, Lee W, Rezaie AR. Polyphosphate elicits pro-inflammatory responses that are counteracted by activated protein C in both cellular and animal models. J Thromb Haemost 2012; 10 (06) 1145-1151
37 Lee JD, Huh JE, Jeon G. , et al. Flavonol-rich RVHxR from Rhus verniciflua Stokes and its major compound fisetin inhibits inflammation-related cytokines and angiogenic factor in rheumatoid arthritic fibroblast-like synovial cells and in vivo models. Int Immunopharmacol 2009; 9 (03) 268-276
38 Bae JS. Role of high mobility group box 1 in inflammatory disease: focus on sepsis. Arch Pharm Res 2012; 35 (09) 1511-1523
39 Russell JA, Walley KR. Update in sepsis 2012. Am J Respir Crit Care Med 2013; 187 (12) 1303-1307
40 Liu G, Wang J, Park YJ. , et al. High mobility group protein-1 inhibits phagocytosis of apoptotic neutrophils through binding to phosphatidylserine. J Immunol 2008; 181 (06) 4240-4246
41 Friggeri A, Yang Y, Banerjee S, Park YJ, Liu G, Abraham E. HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin. Am J Physiol Cell Physiol 2010; 299 (06) C1267-C1276
42 Pisetsky DS. The role of HMGB1 in efferocytosis: when the dead go unburied. Focus on “HMGB1 inhibits macrophage activity in efferocytosis through binding to the alphavbeta3-integrin”. Am J Physiol Cell Physiol 2010; 299 (06) C1253-C1255
43 Poon IK, Lucas CD, Rossi AG, Ravichandran KS. Apoptotic cell clearance: basic biology and therapeutic potential. Nat Rev Immunol 2014; 14 (03) 166-180
44 Matsuda A, Jacob A, Wu R. , et al. Milk fat globule-EGF factor VIII in sepsis and ischemia-reperfusion injury. Mol Med 2011; 17 (1-2): 126-133
45 Hou J, Chen Q, Zhang K. , et al. Sphingosine 1-phosphate receptor 2 signaling suppresses macrophage phagocytosis and impairs host defense against sepsis. Anesthesiology 2015; 123 (02) 409-422
46 Shetty S, Weston CJ, Oo YH. , et al. Common lymphatic endothelial and vascular endothelial receptor-1 mediates the transmigration of regulatory T cells across human hepatic sinusoidal endothelium. J Immunol 2011; 186 (07) 4147-4155
47 Salmi M, Koskinen K, Henttinen T, Elima K, Jalkanen S. CLEVER-1 mediates lymphocyte transmigration through vascular and lymphatic endothelium. Blood 2004; 104 (13) 3849-3857
48 Astiz ME, Rackow EC. Septic shock. Lancet 1998; 351 (9114): 1501-1505
49 Gordon S. The macrophage: past, present and future. Eur J Immunol 2007; 37 (Suppl. 01) S9-S17
50 Hanayama R, Tanaka M, Miyasaka K. , et al. Autoimmune disease and impaired uptake of apoptotic cells in MFG-E8-deficient mice. Science 2004; 304 (5674): 1147-1150
51 Hanayama R, Tanaka M, Miwa K, Shinohara A, Iwamatsu A, Nagata S. Identification of a factor that links apoptotic cells to phagocytes. Nature 2002; 417 (6885): 182-187
52 Cui T, Miksa M, Wu R. , et al. Milk fat globule epidermal growth factor 8 attenuates acute lung injury in mice after intestinal ischemia and reperfusion. Am J Respir Crit Care Med 2010; 181 (03) 238-246
53 Brissette MJ, Lepage S, Lamonde AS. , et al. MFG-E8 released by apoptotic endothelial cells triggers anti-inflammatory macrophage reprogramming. PLoS One 2012; 7 (04) e36368
54 Mogensen TH. Pathogen recognition and inflammatory signaling in innate immune defenses. Clin Microbiol Rev 2009; 22 (02) 240-273
55 Herold S, Mayer K, Lohmeyer J. Acute lung injury: how macrophages orchestrate resolution of inflammation and tissue repair. Front Immunol 2011; 2: 65
56 Belaaouaj A, McCarthy R, Baumann M. , et al. Mice lacking neutrophil elastase reveal impaired host defense against gram negative bacterial sepsis. Nat Med 1998; 4 (05) 615-618
57 Czermak BJ, Sarma V, Pierson CL. , et al. Protective effects of C5a blockade in sepsis. Nat Med 1999; 5 (07) 788-792
58 Underhill DM, Ozinsky A. Phagocytosis of microbes: complexity in action. Annu Rev Immunol 2002; 20: 825-852
59 Palani S, Elima K, Ekholm E, Jalkanen S, Salmi M. Monocyte stabilin-1 suppresses the activation of Th1 lymphocytes. J Immunol 2016; 196 (01) 115-123
60 Hotchkiss RS, Coopersmith CM, McDunn JE, Ferguson TA. The sepsis seesaw: tilting toward immunosuppression. Nat Med 2009; 15 (05) 496-497
61 Ranieri VM, Thompson BT, Barie PS. , et al; PROWESS-SHOCK Study Group. Drotrecogin alfa (activated) in adults with septic shock. N Engl J Med 2012; 366 (22) 2055-2064

Zusatzmaterial

Supplementary Material